{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:23:35Z","timestamp":1789813415502,"version":"4.0.1"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,19]]},"DOI":"10.7759\/cureus.116523","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:56:36Z","timestamp":1789811796000},"source":"Crossref","is-referenced-by-count":0,"title":["Regenerative Medicine in the Management of Musculoskeletal Pain: Mechanisms, Clinical Applications, and Future Directions"],"prefix":"10.7759","author":[{"given":"Salah N","family":"El-Tallawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph V","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq A","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah T","family":"Alsubaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh M","family":"Haddara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania S","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa H","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aalaa M","family":"Doheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S","family":"Nagiub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32340-0","article-title":"Global estimates of the need for rehabilitation based on the Global Burden of Disease Study 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Cieza A","year":"2021","unstructured":"Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the Global Burden of Disease Study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2021, 396:2006-17. 10.1016\/S0140-6736(20)32340-0","journal-title":"Lancet"},{"key":"ref2","article-title":"Global Report on Health Equity for Persons With Disabilities","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global Report on Health Equity for Persons With Disabilities. World Health Organization, Geneva, Switzerland; 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-021-00235-2","article-title":"Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain","volume":"10","author":"El-Tallawy SN","year":"2021","unstructured":"El-Tallawy SN, Nalamasu R, Salem GI, LeQuang JA, Pergolizzi JV, Christo PJ. Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain. Pain Ther. 2021, 10:181-209. 10.1007\/s40122-021-00235-2","journal-title":"Pain Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-016-0496-5","article-title":"Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disorders","volume":"11","author":"Vigan\u00f2 M","year":"2016","unstructured":"Vigan\u00f2 M, Sansone V, d'Agostino MC, Romeo P, Perucca Orfei C, de Girolamo L. Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disorders. J Orthop Surg Res. 2016, 11:163. 10.1186\/s13018-016-0496-5","journal-title":"J Orthop Surg Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2025.032","article-title":"Choosing a nonsteroidal anti-inflammatory drug for pain","volume":"48","author":"Hopkins S","year":"2025","unstructured":"Hopkins S, Yang V, Liew DF. Choosing a nonsteroidal anti-inflammatory drug for pain. Aust Prescr. 2025, 48:139-44. 10.18773\/austprescr.2025.032","journal-title":"Aust Prescr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2013.09.011","article-title":"Long-term use of opioids for complex chronic pain","volume":"27","author":"Von Korff MR","year":"2013","unstructured":"Von Korff MR. Long-term use of opioids for complex chronic pain. Best Pract Res Clin Rheumatol. 2013, 27:663-72. 10.1016\/j.berh.2013.09.011","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.30574\/wjarr.2025.25.3.0702","article-title":"Regenerative medicine in pain control: a review","volume":"25","author":"Bergamaschi LK","year":"2025","unstructured":"Bergamaschi LK, Bergamaschi SLS, Filho PRM, Mardegan KS, Bergamashi RF. Regenerative medicine in pain control: a review. World J Adv Res Rev. 2025, 25:2451-6. 10.30574\/wjarr.2025.25.3.0702","journal-title":"World J Adv Res Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2019-000528","article-title":"How does surgery compare to sham surgery or physiotherapy as a treatment for tendinopathy? A systematic review of randomised trials","volume":"5","author":"Challoumas D","year":"2019","unstructured":"Challoumas D, Clifford C, Kirwan P, Millar NL. How does surgery compare to sham surgery or physiotherapy as a treatment for tendinopathy? A systematic review of randomised trials. BMJ Open Sport Exerc Med. 2019, 5:e000528. 10.1136\/bmjsem-2019-000528","journal-title":"BMJ Open Sport Exerc Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2019.10.007","article-title":"Osteoarthritis: pathology, diagnosis, and treatment options","volume":"104","author":"Abramoff B","year":"2020","unstructured":"Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin North Am. 2020, 104:293-311. 10.1016\/j.mcna.2019.10.007","journal-title":"Med Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1612589","article-title":"The tiny giants of regeneration: MSC-derived extracellular vesicles as next-generation therapeutics","volume":"13","author":"Zhang T","year":"2025","unstructured":"Zhang T, Zhang L, Ma X, Song W. The tiny giants of regeneration: MSC-derived extracellular vesicles as next-generation therapeutics. Front Cell Dev Biol. 2025, 13:1612589. 10.3389\/fcell.2025.1612589","journal-title":"Front Cell Dev Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fresc.2025.1612615","article-title":"Effectiveness of combined regenerative medicine and exercise therapy for patients with knee osteoarthritis: a scoping review","volume":"6","author":"Oka T","year":"2025","unstructured":"Oka T, Suzuki K, Tanaka K, Okuyama K, Kitagawa T. Effectiveness of combined regenerative medicine and exercise therapy for patients with knee osteoarthritis: a scoping review. Front Rehabil Sci. 2025, 6:1612615. 10.3389\/fresc.2025.1612615","journal-title":"Front Rehabil Sci"},{"key":"ref12","unstructured":"National Institutes of Health (US), Office of Research Infrastructure Programs. Stem cells and regenerative medicine. (2026). Accessed. July 27, 2026: https:\/\/orip.nih.gov\/division-comparative-medicine\/initiatives\/stem-cells-and-regenerative-medicine."},{"key":"ref13","unstructured":"US Food and Drug Administration. Focus area. regenerative medicine. (2022). Accessed: July 27, 2026: https:\/\/www.fda.gov\/science-research\/focus-areas-regulatory-science-report\/focus-area-regenerative-medicine."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2013.08.024","article-title":"The clinical status of cartilage tissue regeneration in humans","volume":"21","author":"Mollon B","year":"2013","unstructured":"Mollon B, Kandel R, Chahal J, Theodoropoulos J. The clinical status of cartilage tissue regeneration in humans. Osteoarthritis Cartilage. 2013, 21:1824-33. 10.1016\/j.joca.2013.08.024","journal-title":"Osteoarthritis Cartilage"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1530\/EOR-2025-0050","article-title":"Considerations in modern regenerative medicine for osteoarthritis","volume":"10","author":"Im GI","year":"2025","unstructured":"Im GI. Considerations in modern regenerative medicine for osteoarthritis. EFORT Open Rev. 2025, 10:336-44. 10.1530\/EOR-2025-0050","journal-title":"EFORT Open Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178255","article-title":"Stem cells in regenerative medicine: a journey from adult stem cells to induced pluripotent cells","volume":"26","author":"Della Rocca Y","year":"2025","unstructured":"Della Rocca Y, Mazzone A, Marconi GD, Trubiani O, Pizzicannella J, Diomede F. Stem cells in regenerative medicine: a journey from adult stem cells to induced pluripotent cells. Int J Mol Sci. 2025, 26:8255. 10.3390\/ijms26178255","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-06026-1","article-title":"The efficacy of platelet-rich plasma preparation protocols in the treatment of osteoarthritis: a network meta-analysis of randomized controlled trials","volume":"20","author":"Yu D","year":"2025","unstructured":"Yu D, Zhao J, Zhao K. The efficacy of platelet-rich plasma preparation protocols in the treatment of osteoarthritis: a network meta-analysis of randomized controlled trials. J Orthop Surg Res. 2025, 20:614. 10.1186\/s13018-025-06026-1","journal-title":"J Orthop Surg Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.13107\/jocr.2025.v15.i03.5408","article-title":"Effectiveness of platelet-rich plasma in treating rotator cuff tendinopathy: a systematic review and meta-analysis","volume":"15","author":"Roy M","year":"2025","unstructured":"Roy M, Reddy MH, Das D, Priyanshu, Chandrakar D, Elavarasu AM. Effectiveness of platelet-rich plasma in treating rotator cuff tendinopathy: a systematic review and meta-analysis. J Orthop Case Rep. 2025, 15:265-74. 10.13107\/jocr.2025.v15.i03.5408","journal-title":"J Orthop Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102100","article-title":"Immunomodulatory biomaterials for osteoarthritis: targeting inflammation and enhancing cartilage regeneration","volume":"34","author":"Zhao R","year":"2025","unstructured":"Zhao R, Liang B, Shi Y, et al.. Immunomodulatory biomaterials for osteoarthritis: targeting inflammation and enhancing cartilage regeneration. Mater Today Bio. 2025, 34:102100. 10.1016\/j.mtbio.2025.102100","journal-title":"Mater Today Bio"},{"key":"ref20","unstructured":"Stokes DJ, Frank RM. Platelet-rich plasma for osteoarthritis in 2024 - more hype. (2024). Accessed. June 30, 2025: https:\/\/www.sportsmed.org\/membership\/sports-medicine-update\/spring-2024\/platelet-rich-plasma-for-osteoarthritis-in-2024."},{"key":"ref21","unstructured":"Dr Iain Duncan. A comprehensive review of platelet-rich plasma in osteoarthritis management. (2025). Accessed. July 27, 2026: https:\/\/driainduncan.com.au\/prp-review-2025.html."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010043","article-title":"Extracellular vesicles in musculoskeletal regeneration: modulating the therapy of the future","volume":"11","author":"Abreu H","year":"2021","unstructured":"Abreu H, Canciani E, Raineri D, Cappellano G, Rimondini L, Chiocchetti A. Extracellular vesicles in musculoskeletal regeneration: modulating the therapy of the future. Cells. 2021, 11:43. 10.3390\/cells11010043","journal-title":"Cells"},{"key":"ref23","unstructured":"Oxford Centre for Evidence-Based Medicine. OCEBM levels of evidence. (2020). Accessed. July 27, 2026: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.150734","article-title":"Principles and methods of preparation of platelet-rich plasma: a review and author's perspective","volume":"7","author":"Dhurat R","year":"2014","unstructured":"Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author's perspective. J Cutan Aesthet Surg. 2014, 7:189-97. 10.4103\/0974-2077.150734","journal-title":"J Cutan Aesthet Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_1050_20","article-title":"A cross-sectional analysis of the effects of various centrifugation speeds and inclusion of the buffy coat in platelet-rich plasma preparation","volume":"87","author":"Muthuprabakaran K","year":"2021","unstructured":"Muthuprabakaran K, Pai VV, Ahmad S, Shukla P. A cross-sectional analysis of the effects of various centrifugation speeds and inclusion of the buffy coat in platelet-rich plasma preparation. Indian J Dermatol Venereol Leprol. 2021, 87:792-9. 10.25259\/IJDVL_1050_20","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000044929","article-title":"Comparative efficacy of intra-articular platelet-rich plasma, hyaluronic acid, corticosteroids, and NSAIDs for knee osteoarthritis: a retrospective cohort study","volume":"104","author":"G\u00f6k\u00e7eo\u011flu YS","year":"2025","unstructured":"G\u00f6k\u00e7eo\u011flu YS, Yapti M, \u00d6ncel F, Levent A, Demir S. Comparative efficacy of intra-articular platelet-rich plasma, hyaluronic acid, corticosteroids, and NSAIDs for knee osteoarthritis: a retrospective cohort study. Medicine (Baltimore). 2025, 104:e44929. 10.1097\/MD.0000000000044929","journal-title":"Medicine (Baltimore)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz011","article-title":"Meta-analysis comparing platelet-rich plasma vs hyaluronic acid injection in patients with knee osteoarthritis","volume":"20","author":"Han Y","year":"2019","unstructured":"Han Y, Huang H, Pan J, et al.. Meta-analysis comparing platelet-rich plasma vs hyaluronic acid injection in patients with knee osteoarthritis. Pain Med. 2019, 20:1418-29. 10.1093\/pm\/pnz011","journal-title":"Pain Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2020.07.011","article-title":"Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis of 26 randomized controlled trials","volume":"37","author":"Tan J","year":"2021","unstructured":"Tan J, Chen H, Zhao L, Huang W. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis of 26 randomized controlled trials. Arthroscopy. 2021, 37:309-25. 10.1016\/j.arthro.2020.07.011","journal-title":"Arthroscopy"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2023.10.015","article-title":"The efficacy of platelet-rich plasma injections compared to corticosteroids and physiotherapy in adhesive capsulitis: a systematic review and meta-analysis","volume":"47","author":"Pretorius J","year":"2024","unstructured":"Pretorius J, Mirdad R, Nemat N, Ghobrial BZ, Murphy C. The efficacy of platelet-rich plasma injections compared to corticosteroids and physiotherapy in adhesive capsulitis: a systematic review and meta-analysis. J Orthop. 2024, 47:35-44. 10.1016\/j.jor.2023.10.015","journal-title":"J Orthop"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02313-9","article-title":"Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies","volume":"10","author":"Han X","year":"2025","unstructured":"Han X, Liao R, Li X, et al.. Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target Ther. 2025, 10:262. 10.1038\/s41392-025-02313-9","journal-title":"Signal Transduct Target Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1602727","article-title":"Hypertonic dextrose prolotherapy in osteoarthritis: mechanisms, efficacy, and future research directions","volume":"16","author":"Huang K","year":"2025","unstructured":"Huang K, Cai H. Hypertonic dextrose prolotherapy in osteoarthritis: mechanisms, efficacy, and future research directions. Front Endocrinol (Lausanne). 2025, 16:1602727. 10.3389\/fendo.2025.1602727","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/23259671251356628","article-title":"Platelet-poor plasma for muscle injuries: a review of mechanisms and clinical perspectives","volume":"13","author":"Fernandes GC","year":"2025","unstructured":"Fernandes GC, Rodeo SA. Platelet-poor plasma for muscle injuries: a review of mechanisms and clinical perspectives. Orthop J Sports Med. 2025, 13:10.1177\/23259671251356628","journal-title":"Orthop J Sports Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03253-4","article-title":"Efficacy and safety of platelet-rich plasma injections for the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Wang C","year":"2025","unstructured":"Wang C, Yao B. Efficacy and safety of platelet-rich plasma injections for the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Eur J Med Res. 2025, 30:992. 10.1186\/s40001-025-03253-4","journal-title":"Eur J Med Res"},{"key":"ref34","article-title":"Comprehensive evidence-based guidelines for regenerative therapies in the management of chronic low back pain: 2025 update from the American Society of Interventional Pain Physicians (ASIPP)","volume":"28","author":"Manchikanti L","year":"2025","unstructured":"Manchikanti L, Navani R, Navani A, et al.. Comprehensive evidence-based guidelines for regenerative therapies in the management of chronic low back pain: 2025 update from the American Society of Interventional Pain Physicians (ASIPP). Pain Physician. 2025, 28:S1-119.","journal-title":"Pain Physician"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/0363546519881423","article-title":"Use of platelet-rich plasma for the improvement of pain and function in rotator cuff tears: a systematic review and meta-analysis with bias assessment","volume":"48","author":"Chen X","year":"2020","unstructured":"Chen X, Jones IA, Togashi R, Park C, Vangsness CT Jr. Use of platelet-rich plasma for the improvement of pain and function in rotator cuff tears: a systematic review and meta-analysis with bias assessment. Am J Sports Med. 2020, 48:2028-41. 10.1177\/0363546519881423","journal-title":"Am J Sports Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1390030","article-title":"US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine","volume":"28","author":"Beitzel K","year":"2015","unstructured":"Beitzel K, Allen D, Apostolakos J, et al.. US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine. J Knee Surg. 2015, 28:29-34. 10.1055\/s-0034-1390030","journal-title":"J Knee Surg"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/ksa.12682","article-title":"Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: a 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections)","volume":"33","author":"Eymard F","year":"2025","unstructured":"Eymard F, Louati K, Noel \u00c9, et al.. Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: a 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections). Knee Surg Sports Traumatol Arthrosc. 2025, 33:2293-306. 10.1002\/ksa.12682","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147914","article-title":"Profound properties of protein-rich, platelet-rich plasma matrices as novel, multi-purpose biological platforms in tissue repair, regeneration, and wound healing","volume":"25","author":"Everts PA","year":"2024","unstructured":"Everts PA, Lana JF, Alexander RW, et al.. Profound properties of protein-rich, platelet-rich plasma matrices as novel, multi-purpose biological platforms in tissue repair, regeneration, and wound healing. Int J Mol Sci. 2024, 25:7914. 10.3390\/ijms25147914","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.26717\/BJSTR.2019.18.003191","article-title":"Expressions of growth factors in autologous derived platelet-rich plasma and platelet-poor plasma; implication for tissue reparation and wound healing","volume":"18","author":"Akingboye AA","year":"2019","unstructured":"Akingboye AA, Kyriakides C, Tucker AT. Expressions of growth factors in autologous derived platelet-rich plasma and platelet-poor plasma; implication for tissue reparation and wound healing. Biomed J Sci Tech Res. 2019, 18:13790-6. 10.26717\/BJSTR.2019.18.003191","journal-title":"Biomed J Sci Tech Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-012-9957-3","article-title":"Protocol for obtaining platelet-rich plasma (PRP), platelet-poor plasma (PPP), and thrombin for autologous use","volume":"36","author":"Franco D","year":"2012","unstructured":"Franco D, Franco T, Schettino AM, Filho JM, Vendramin FS. Protocol for obtaining platelet-rich plasma (PRP), platelet-poor plasma (PPP), and thrombin for autologous use. Aesthetic Plast Surg. 2012, 36:1254-9. 10.1007\/s00266-012-9957-3","journal-title":"Aesthetic Plast Surg"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039885","article-title":"Current advances in the treatment of myofascial pain syndrome with trigger point injections: a review","volume":"103","author":"Anwar N","year":"2024","unstructured":"Anwar N, Wei X, Jie Y, Hongbo Z, Jin H, Zhu Z. Current advances in the treatment of myofascial pain syndrome with trigger point injections: a review. Medicine (Baltimore). 2024, 103:e39885. 10.1097\/MD.0000000000039885","journal-title":"Medicine (Baltimore)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1249\/JSR.0000000000001173","article-title":"Platelet-poor versus platelet-rich plasma for the treatment of muscle injuries","volume":"23","author":"Raum G","year":"2024","unstructured":"Raum G, Kenyon C, Bowers R. Platelet-poor versus platelet-rich plasma for the treatment of muscle injuries. Curr Sports Med Rep. 2024, 23:222-8. 10.1249\/JSR.0000000000001173","journal-title":"Curr Sports Med Rep"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2015-094603","article-title":"Platelet-rich plasma does not enhance return to play in hamstring injuries: a randomised controlled trial","volume":"49","author":"Hamilton B","year":"2015","unstructured":"Hamilton B, Tol JL, Almusa E, et al.. Platelet-rich plasma does not enhance return to play in hamstring injuries: a randomised controlled trial. Br J Sports Med. 2015, 49:943-50. 10.1136\/bjsports-2015-094603","journal-title":"Br J Sports Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-822902-6.00018-0","article-title":"Chapter 1 - Autologous blood: platelet-rich plasma and platelet-poor plasma","author":"Gobbi A","year":"2025","unstructured":"Gobbi A, Herman K, Dallo I, Bizzoco L, Acosta M IV. Chapter 1 - Autologous blood: platelet-rich plasma and platelet-poor plasma. OrthoBiologics. Frank RM, Jackson GR, Chahla J (ed): Academic Press, Cambridge, MA; 2025. 10.1016\/B978-0-12-822902-6.00018-0"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1177\/03635465241239062","article-title":"Leukocyte-poor platelet-rich plasma as an adjuvant to arthroscopic rotator cuff repair reduces the retear rate but does not improve functional outcomes: a double-blind randomized controlled trial","volume":"52","author":"Rossi LA","year":"2024","unstructured":"Rossi LA, Gorodischer TD, Camino P, Brandariz RN, Tanoira I, Piuzzi NS, Ranalletta M. Leukocyte-poor platelet-rich plasma as an adjuvant to arthroscopic rotator cuff repair reduces the retear rate but does not improve functional outcomes: a double-blind randomized controlled trial. Am J Sports Med. 2024, 52:1403-10. 10.1177\/03635465241239062","journal-title":"Am J Sports Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-025-09123-8","article-title":"Mesenchymal stem cells injections in traumatology and orthopaedics: Common practice or still a promising area with many uncertainties?","volume":"26","author":"Bezuglov E","year":"2025","unstructured":"Bezuglov E, Dolgalev I, Kuznetsova M, et al.. Mesenchymal stem cells injections in traumatology and orthopaedics: Common practice or still a promising area with many uncertainties?. BMC Musculoskelet Disord. 2025, 26:840. 10.1186\/s12891-025-09123-8","journal-title":"BMC Musculoskelet Disord"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150025","article-title":"Human mesenchymal stem cells - current trends and future prospective","volume":"35","author":"Ullah I","year":"2015","unstructured":"Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015, 35:e00191. 10.1042\/BSR20150025","journal-title":"Biosci Rep"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1159\/000469704","article-title":"Role of mesenchymal stem cells in bone regenerative medicine: What is the evidence?","volume":"204","author":"Oryan A","year":"2017","unstructured":"Oryan A, Kamali A, Moshiri A, Baghaban Eslaminejad M. Role of mesenchymal stem cells in bone regenerative medicine: What is the evidence?. Cells Tissues Organs. 2017, 204:59-83. 10.1159\/000469704","journal-title":"Cells Tissues Organs"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105236","article-title":"Oral bone tissue regeneration: mesenchymal stem cells, secretome, and biomaterials","volume":"22","author":"Gugliandolo A","year":"2021","unstructured":"Gugliandolo A, Fonticoli L, Trubiani O, et al.. Oral bone tissue regeneration: mesenchymal stem cells, secretome, and biomaterials. Int J Mol Sci. 2021, 22:5236. 10.3390\/ijms22105236","journal-title":"Int J Mol Sci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2560174","article-title":"Recent advance in source, property, differentiation, and applications of infrapatellar fat pad adipose-derived stem cells","volume":"2020","author":"Zhong YC","year":"2020","unstructured":"Zhong YC, Wang SC, Han YH, Wen Y. Recent advance in source, property, differentiation, and applications of infrapatellar fat pad adipose-derived stem cells. Stem Cells Int. 2020, 2020:2560174. 10.1155\/2020\/2560174","journal-title":"Stem Cells Int"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143430","article-title":"Genetically engineered-MSC therapies for non-unions, delayed unions and critical-size bone defects","volume":"20","author":"Freitas J","year":"2019","unstructured":"Freitas J, Santos SG, Gon\u00e7alves RM, Teixeira JH, Barbosa MA, Almeida MI. Genetically engineered-MSC therapies for non-unions, delayed unions and critical-size bone defects. Int J Mol Sci. 2019, 20:3430. 10.3390\/ijms20143430","journal-title":"Int J Mol Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.22203\/ecm.v029a02","article-title":"Systemic mesenchymal stem cell administration enhances bone formation in fracture repair but not load-induced bone formation","volume":"29","author":"Rapp AE","year":"2015","unstructured":"Rapp AE, Bindl R, Heilmann A, Erbacher A, M\u00fcller I, Brenner RE, Ignatius A. Systemic mesenchymal stem cell administration enhances bone formation in fracture repair but not load-induced bone formation. Eur Cell Mater. 2015, 29:22-34. 10.22203\/ecm.v029a02","journal-title":"Eur Cell Mater"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.05.004","article-title":"Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?","volume":"70","author":"Trigo CM","year":"2025","unstructured":"Trigo CM, Rodrigues JS, Cam\u00f5es SP, Sol\u00e1 S, Miranda JP. Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?. J Adv Res. 2025, 70:103-24. 10.1016\/j.jare.2024.05.004","journal-title":"J Adv Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.7150\/thno.48080","article-title":"Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p\/Sirt1\/p53 axis","volume":"11","author":"Cheng T","year":"2021","unstructured":"Cheng T, Ding S, Liu S, Li Y, Sun L. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p\/Sirt1\/p53 axis. Theranostics. 2021, 11:893-905. 10.7150\/thno.48080","journal-title":"Theranostics"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115167","article-title":"Mesenchymal stem cells derived extracellular vesicles: a promising nanomedicine for drug delivery system","volume":"203","author":"Rezaie J","year":"2022","unstructured":"Rezaie J, Nejati V, Mahmoodi M, Ahmadi M. Mesenchymal stem cells derived extracellular vesicles: a promising nanomedicine for drug delivery system. Biochem Pharmacol. 2022, 203:115167. 10.1016\/j.bcp.2022.115167","journal-title":"Biochem Pharmacol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207334","article-title":"An update on adipose-derived stem cells for regenerative medicine: where challenge meets opportunity","volume":"10","author":"Qin Y","year":"2023","unstructured":"Qin Y, Ge G, Yang P, et al.. An update on adipose-derived stem cells for regenerative medicine: where challenge meets opportunity. Adv Sci (Weinh). 2023, 10:e2207334. 10.1002\/advs.202207334","journal-title":"Adv Sci (Weinh)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-026-00877-0","article-title":"Microfragmented adipose tissue in pain management: bridging regenerative biology and clinical therapeutics","author":"Van Tran Y","year":"2026","unstructured":"Van Tran Y, Van Pham P, Encinas MN, et al.. Microfragmented adipose tissue in pain management: bridging regenerative biology and clinical therapeutics. Pain Ther. 2026, 10.1007\/s40122-026-00877-0","journal-title":"Pain Ther"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s40778-016-0053-5","article-title":"Adipose tissue and mesenchymal stem cells: state of the art and Lipogems\u00ae technology development","volume":"2","author":"Tremolada C","year":"2016","unstructured":"Tremolada C, Colombo V, Ventura C. Adipose tissue and mesenchymal stem cells: state of the art and Lipogems\u00ae technology development. Curr Stem Cell Rep. 2016, 2:304-12. 10.1007\/s40778-016-0053-5","journal-title":"Curr Stem Cell Rep"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.18-0051","article-title":"Higher pericyte content and secretory activity of microfragmented human adipose tissue compared to enzymatically derived stromal vascular fraction","volume":"7","author":"Vezzani B","year":"2018","unstructured":"Vezzani B, Shaw I, Lesme H, Yong L, Khan N, Tremolada C, P\u00e9ault B. Higher pericyte content and secretory activity of microfragmented human adipose tissue compared to enzymatically derived stromal vascular fraction. Stem Cells Transl Med. 2018, 7:876-86. 10.1002\/sctm.18-0051","journal-title":"Stem Cells Transl Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjag025","article-title":"A scoping review on mechanically micronized adipose-derived products: technological innovations and regenerative potential","author":"Ma X","year":"2026","unstructured":"Ma X, Li Z, Zhang Y, Dong M, Li F, Wang X. A scoping review on mechanically micronized adipose-derived products: technological innovations and regenerative potential. Aesthet Surg J. 2026, sjag025. 10.1093\/asj\/sjag025","journal-title":"Aesthet Surg J"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052425","article-title":"Adipose tissue-derived mesenchymal stem\/stromal cells and their contribution to angiogenic processes in tissue regeneration","volume":"23","author":"Krawczenko A","year":"2022","unstructured":"Krawczenko A, Klimczak A. Adipose tissue-derived mesenchymal stem\/stromal cells and their contribution to angiogenic processes in tissue regeneration. Int J Mol Sci. 2022, 23:2425. 10.3390\/ijms23052425","journal-title":"Int J Mol Sci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.13251","article-title":"The paradigm of stem cell secretome in tissue repair and regeneration: present and future perspectives","volume":"33","author":"Da Silva K","year":"2025","unstructured":"Da Silva K, Kumar P, Choonara YE. The paradigm of stem cell secretome in tissue repair and regeneration: present and future perspectives. Wound Repair Regen. 2025, 33:e13251. 10.1111\/wrr.13251","journal-title":"Wound Repair Regen"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/jeo2.70144","article-title":"Arthroscopic debridement followed by intra-articular injection of micro-fragmented adipose tissue in patients affected by knee osteoarthritis: clinical results up to 48 months from a prospective clinical study","volume":"12","author":"Bruno AA","year":"2025","unstructured":"Bruno AA, Anzillotti G, De Donato M, et al.. Arthroscopic debridement followed by intra-articular injection of micro-fragmented adipose tissue in patients affected by knee osteoarthritis: clinical results up to 48 months from a prospective clinical study. J Exp Orthop. 2025, 12:e70144. 10.1002\/jeo2.70144","journal-title":"J Exp Orthop"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.52628\/90.3.12669","article-title":"Microfragmented adipose tissue versus platelet-rich plasma in the treatment of knee osteoarthritis: a systematic review and meta-analysis","volume":"90","author":"Ye X","year":"2024","unstructured":"Ye X, Shen Z, Li X, Zhang B, Shen G, Wu L. Microfragmented adipose tissue versus platelet-rich plasma in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Acta Orthop Belg. 2024, 90:549-58. 10.52628\/90.3.12669","journal-title":"Acta Orthop Belg"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-019-05621-0","article-title":"Micro-fragmented stromal-vascular fraction plus microfractures provides better clinical results than microfractures alone in symptomatic focal chondral lesions of the knee","volume":"28","author":"Bisicchia S","year":"2020","unstructured":"Bisicchia S, Bernardi G, Pagnotta SM, Tudisco C. Micro-fragmented stromal-vascular fraction plus microfractures provides better clinical results than microfractures alone in symptomatic focal chondral lesions of the knee. Knee Surg Sports Traumatol Arthrosc. 2020, 28:1876-84. 10.1007\/s00167-019-05621-0","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1177\/03635465221083324","article-title":"Arthroscopic rotator cuff repair augmentation with autologous microfragmented lipoaspirate tissue is safe and effectively improves short-term clinical and functional results: a prospective randomized controlled trial with 24-month follow-up","volume":"50","author":"Randelli PS","year":"2022","unstructured":"Randelli PS, Cucchi D, Fossati C, Boerci L, Nocerino E, Ambrogi F, Menon A. Arthroscopic rotator cuff repair augmentation with autologous microfragmented lipoaspirate tissue is safe and effectively improves short-term clinical and functional results: a prospective randomized controlled trial with 24-month follow-up. Am J Sports Med. 2022, 50:1344-57. 10.1177\/03635465221083324","journal-title":"Am J Sports Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0710-3","article-title":"Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study","volume":"8","author":"Kumar H","year":"2017","unstructured":"Kumar H, Ha DH, Lee EJ, et al.. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study. Stem Cell Res Ther. 2017, 8:262. 10.1186\/s13287-017-0710-3","journal-title":"Stem Cell Res Ther"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00131","article-title":"Human umbilical mesenchymal stem cells display therapeutic potential in rheumatoid arthritis by regulating interactions between immunity and gut microbiota via the aryl hydrocarbon receptor","volume":"8","author":"Li X","year":"2020","unstructured":"Li X, Lu C, Fan D, et al.. Human umbilical mesenchymal stem cells display therapeutic potential in rheumatoid arthritis by regulating interactions between immunity and gut microbiota via the aryl hydrocarbon receptor. Front Cell Dev Biol. 2020, 8:131. 10.3389\/fcell.2020.00131","journal-title":"Front Cell Dev Biol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112478","article-title":"Advancing osteoarthritis treatment: the therapeutic potential of mesenchymal stem cell-derived exosomes and biomaterial integration","volume":"12","author":"Chu CH","year":"2024","unstructured":"Chu CH, Lee RP, Wu WT, Chen IH, Yeh KT, Wang CC. Advancing osteoarthritis treatment: the therapeutic potential of mesenchymal stem cell-derived exosomes and biomaterial integration. Biomedicines. 2024, 12:2478. 10.3390\/biomedicines12112478","journal-title":"Biomedicines"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00997","article-title":"Mesenchymal stem cell-derived extracellular vesicles: opportunities and challenges for clinical translation","volume":"8","author":"Maumus M","year":"2020","unstructured":"Maumus M, Rozier P, Boulestreau J, Jorgensen C, No\u00ebl D. Mesenchymal stem cell-derived extracellular vesicles: opportunities and challenges for clinical translation. Front Bioeng Biotechnol. 2020, 8:997. 10.3389\/fbioe.2020.00997","journal-title":"Front Bioeng Biotechnol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2011.10.005","article-title":"Exosomes: small vesicles participating in intercellular communication","volume":"44","author":"Ludwig AK","year":"2012","unstructured":"Ludwig AK, Giebel B. Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol. 2012, 44:11-5. 10.1016\/j.biocel.2011.10.005","journal-title":"Int J Biochem Cell Biol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo M","year":"2014","unstructured":"Colombo M, Raposo G, Th\u00e9ry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014, 30:255-89. 10.1146\/annurev-cellbio-101512-122326","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel G","year":"2018","unstructured":"van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018, 19:213-28. 10.1038\/nrm.2017.125","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3MR0120-232R","article-title":"Chicken-or-egg question: Which came first, extracellular vesicles or autoimmune diseases?","volume":"108","author":"Maione F","year":"2020","unstructured":"Maione F, Cappellano G, Bellan M, Raineri D, Chiocchetti A. Chicken-or-egg question: Which came first, extracellular vesicles or autoimmune diseases?. J Leukoc Biol. 2020, 108:601-16. 10.1002\/JLB.3MR0120-232R","journal-title":"J Leukoc Biol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04879-1","article-title":"Mesenchymal stem cell-derived extracellular vesicles in musculoskeletal regeneration: mechanisms, applications, and future prospects","volume":"17","author":"Aziziyan F","year":"2026","unstructured":"Aziziyan F, Asl SS, Mahdipour M, Fard RN, Sheykhhasan M. Mesenchymal stem cell-derived extracellular vesicles in musculoskeletal regeneration: mechanisms, applications, and future prospects. Stem Cell Res Ther. 2026, 17:66. 10.1186\/s13287-025-04879-1","journal-title":"Stem Cell Res Ther"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70205","article-title":"The role of extracellular vesicles in musculoskeletal diseases","volume":"14","author":"Fu PJ","year":"2025","unstructured":"Fu PJ, Luo Y, Zheng SY, Ma ZR, Xiao WF, Li H, Li YS. The role of extracellular vesicles in musculoskeletal diseases. J Extracell Vesicles. 2025, 14:e70205. 10.1002\/jev2.70205","journal-title":"J Extracell Vesicles"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S441467","article-title":"Mesenchymal stem cell-derived extracellular vesicles in bone-related diseases: intercellular communication messengers and therapeutic engineering protagonists","volume":"19","author":"Wang Y","year":"2024","unstructured":"Wang Y, Wen J, Lu T, Han W, Jiao K, Li H. Mesenchymal stem cell-derived extracellular vesicles in bone-related diseases: intercellular communication messengers and therapeutic engineering protagonists. Int J Nanomedicine. 2024, 19:3233-57. 10.2147\/IJN.S441467","journal-title":"Int J Nanomedicine"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S424731","article-title":"Harnessing stem cell-derived extracellular vesicles for the regeneration of degenerative bone conditions","volume":"18","author":"Jia Z","year":"2023","unstructured":"Jia Z, Zhang S, Li W. Harnessing stem cell-derived extracellular vesicles for the regeneration of degenerative bone conditions. Int J Nanomedicine. 2023, 18:5561-78. 10.2147\/IJN.S424731","journal-title":"Int J Nanomedicine"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101864","article-title":"MSC-EVs alleviate osteoarthritis by regulating microenvironmental cells in the articular cavity and maintaining cartilage matrix homeostasis","volume":"85","author":"You B","year":"2023","unstructured":"You B, Zhou C, Yang Y. MSC-EVs alleviate osteoarthritis by regulating microenvironmental cells in the articular cavity and maintaining cartilage matrix homeostasis. Ageing Res Rev. 2023, 85:101864. 10.1016\/j.arr.2023.101864","journal-title":"Ageing Res Rev"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2024.07.005","article-title":"Mesenchymal stem cell-derived extracellular vesicles in joint diseases: therapeutic effects and underlying mechanisms","volume":"48","author":"Wu J","year":"2024","unstructured":"Wu J, Wu J, Liu Z, et al.. Mesenchymal stem cell-derived extracellular vesicles in joint diseases: therapeutic effects and underlying mechanisms. J Orthop Translat. 2024, 48:53-69. 10.1016\/j.jot.2024.07.005","journal-title":"J Orthop Translat"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092241","article-title":"Stem cells and exosomes: new therapies for intervertebral disc degeneration","volume":"10","author":"Krut Z","year":"2021","unstructured":"Krut Z, Pelled G, Gazit D, Gazit Z. Stem cells and exosomes: new therapies for intervertebral disc degeneration. Cells. 2021, 10:2241. 10.3390\/cells10092241","journal-title":"Cells"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3390\/nu16183097","article-title":"Functional role of extracellular vesicles in skeletal muscle physiology and sarcopenia: the importance of physical exercise and nutrition","volume":"16","author":"Lombardo M","year":"2024","unstructured":"Lombardo M, Aiello G, Fratantonio D, Karav S, Baldelli S. Functional role of extracellular vesicles in skeletal muscle physiology and sarcopenia: the importance of physical exercise and nutrition. Nutrients. 2024, 16:3097. 10.3390\/nu16183097","journal-title":"Nutrients"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2019.3778","article-title":"Intervertebral disc tissue engineering: a brief review","volume":"19","author":"Stergar J","year":"2019","unstructured":"Stergar J, Gradisnik L, Velnar T, Maver U. Intervertebral disc tissue engineering: a brief review. Bosn J Basic Med Sci. 2019, 19:130-7. 10.17305\/bjbms.2019.3778","journal-title":"Bosn J Basic Med Sci"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02075-y","article-title":"Degenerated nucleus pulposus cells derived exosome carrying miR-27a-3p aggravates intervertebral disc degeneration by inducing M1 polarization of macrophages","volume":"21","author":"Zhao X","year":"2023","unstructured":"Zhao X, Sun Z, Xu B, Duan W, Chang L, Lai K, Ye Z. Degenerated nucleus pulposus cells derived exosome carrying miR-27a-3p aggravates intervertebral disc degeneration by inducing M1 polarization of macrophages. J Nanobiotechnology. 2023, 21:317. 10.1186\/s12951-023-02075-y","journal-title":"J Nanobiotechnology"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1625787","article-title":"Trends in mesenchymal stem cell-derived extracellular vesicles clinical trials 2014-2024: Is efficacy optimal in a narrow dose range?","volume":"12","author":"Wang Y","year":"2025","unstructured":"Wang Y, Zhu J, Ma Q, et al.. Trends in mesenchymal stem cell-derived extracellular vesicles clinical trials 2014-2024: Is efficacy optimal in a narrow dose range?. Front Med (Lausanne). 2025, 12:1625787. 10.3389\/fmed.2025.1625787","journal-title":"Front Med (Lausanne)"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116063","article-title":"Mesenchymal stromal cell-based products: challenges and clinical therapeutic options","volume":"25","author":"Mello DB","year":"2024","unstructured":"Mello DB, Mesquita FC, Silva Dos Santos D, et al.. Mesenchymal stromal cell-based products: challenges and clinical therapeutic options. Int J Mol Sci. 2024, 25:6063. 10.3390\/ijms25116063","journal-title":"Int J Mol Sci"},{"key":"ref87","unstructured":"US Food and Drug Administration. Important patient and consumer information about regenerative medicine therapies. (2024). Accessed. July 27, 2026: https:\/\/www.fda.gov\/vaccines-blood-biologics\/consumers-biologics\/important-patient-and-consumer-information-about-reg...."},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1568914","article-title":"Challenges and future perspectives in using mesenchymal stem cells for efficient bone fracture healing","volume":"13","author":"Han D","year":"2025","unstructured":"Han D, Liu W, Gong J, Ma Y, Sun Z. Challenges and future perspectives in using mesenchymal stem cells for efficient bone fracture healing. Front Bioeng Biotechnol. 2025, 13:1568914. 10.3389\/fbioe.2025.1568914","journal-title":"Front Bioeng Biotechnol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri R","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020, 367:10.1126\/science.aau6977","journal-title":"Science"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine. 2020, 15:6917-34. 10.2147\/IJN.S264498","journal-title":"Int J Nanomedicine"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik NP","year":"2018","unstructured":"Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018, 75:193-208. 10.1007\/s00018-017-2595-9","journal-title":"Cell Mol Life Sci"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/21.6.1289","article-title":"Late endosome motility depends on lipids via the small GTPase Rab7","volume":"21","author":"Lebrand C","year":"2002","unstructured":"Lebrand C, Corti M, Goodson H, et al.. Late endosome motility depends on lipids via the small GTPase Rab7. EMBO J. 2002, 21:1289-300. 10.1093\/emboj\/21.6.1289","journal-title":"EMBO J"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13904","article-title":"Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes","volume":"17","author":"Wang CK","year":"2024","unstructured":"Wang CK, Tsai TH, Lee CH. Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024, 17:e13904. 10.1111\/cts.13904","journal-title":"Clin Transl Sci"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00149","article-title":"Mesenchymal stem cell-derived extracellular vesicles: challenges in clinical applications","volume":"8","author":"Gowen A","year":"2020","unstructured":"Gowen A, Shahjin F, Chand S, Odegaard KE, Yelamanchili SV. Mesenchymal stem cell-derived extracellular vesicles: challenges in clinical applications. Front Cell Dev Biol. 2020, 8:149. 10.3389\/fcell.2020.00149","journal-title":"Front Cell Dev Biol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4150705","article-title":"MiRNA-sequence indicates that mesenchymal stem cells and exosomes have similar mechanism to enhance cardiac repair","volume":"2017","author":"Shao L","year":"2017","unstructured":"Shao L, Zhang Y, Lan B, et al.. MiRNA-sequence indicates that mesenchymal stem cells and exosomes have similar mechanism to enhance cardiac repair. Biomed Res Int. 2017, 2017:4150705. 10.1155\/2017\/4150705","journal-title":"Biomed Res Int"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-013-1110-5","article-title":"Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model","volume":"92","author":"Bian S","year":"2014","unstructured":"Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl). 2014, 92:387-97. 10.1007\/s00109-013-1110-5","journal-title":"J Mol Med (Berl)"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.114173","article-title":"Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension","volume":"126","author":"Lee C","year":"2012","unstructured":"Lee C, Mitsialis SA, Aslam M, et al.. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012, 126:2601-11. 10.1161\/CIRCULATIONAHA.112.114173","journal-title":"Circulation"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2014.0316","article-title":"Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro","volume":"24","author":"Shabbir A","year":"2015","unstructured":"Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev. 2015, 24:1635-47. 10.1089\/scd.2014.0316","journal-title":"Stem Cells Dev"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0417-0","article-title":"Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis","volume":"13","author":"Zhang J","year":"2015","unstructured":"Zhang J, Guan J, Niu X, et al.. Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J Transl Med. 2015, 13:49. 10.1186\/s12967-015-0417-0","journal-title":"J Transl Med"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1073140","article-title":"Extracellular vesicles: evolving factors in stem cell biology","volume":"2016","author":"Nawaz M","year":"2016","unstructured":"Nawaz M, Fatima F, Vallabhaneni KC, et al.. Extracellular vesicles: evolving factors in stem cell biology. Stem Cells Int. 2016, 2016:1073140. 10.1155\/2016\/1073140","journal-title":"Stem Cells Int"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v12.i8.814","article-title":"Mesenchymal stem cell-derived exosomes: toward cell-free therapeutic strategies in regenerative medicine","volume":"12","author":"Ma ZJ","year":"2020","unstructured":"Ma ZJ, Yang JJ, Lu YB, Liu ZY, Wang XX. Mesenchymal stem cell-derived exosomes: toward cell-free therapeutic strategies in regenerative medicine. World J Stem Cells. 2020, 12:814-40. 10.4252\/wjsc.v12.i8.814","journal-title":"World J Stem Cells"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2024.08.001","article-title":"Harnessing the potential of mesenchymal stem cells-derived exosomes in degenerative diseases","volume":"26","author":"Liao HJ","year":"2024","unstructured":"Liao HJ, Yang YP, Liu YH, Tseng HC, Huo TI, Chiou SH, Chang CH. Harnessing the potential of mesenchymal stem cells-derived exosomes in degenerative diseases. Regen Ther. 2024, 26:599-610. 10.1016\/j.reth.2024.08.001","journal-title":"Regen Ther"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering12080844","article-title":"Immunomodulatory and regenerative functions of MSC-derived exosomes in bone repair","volume":"12","author":"Arun M","year":"2025","unstructured":"Arun M, Rajasingh S, Madasamy P, Rajasingh J. Immunomodulatory and regenerative functions of MSC-derived exosomes in bone repair. Bioengineering (Basel). 2025, 12:844. 10.3390\/bioengineering12080844","journal-title":"Bioengineering (Basel)"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1539714","article-title":"The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer","volume":"12","author":"Odehnalov\u00e1 N","year":"2025","unstructured":"Odehnalov\u00e1 N, \u0160andrikov\u00e1 V, Hromadka R, et al.. The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer. Front Med (Lausanne). 2025, 12:1539714. 10.3389\/fmed.2025.1539714","journal-title":"Front Med (Lausanne)"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.28","article-title":"Gene therapy approaches to regenerating the musculoskeletal system","volume":"11","author":"Evans CH","year":"2015","unstructured":"Evans CH, Huard J. Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol. 2015, 11:234-42. 10.1038\/nrrheum.2015.28","journal-title":"Nat Rev Rheumatol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202271","article-title":"Engineering inflammation-resistant cartilage: bridging gene therapy and tissue engineering","volume":"12","author":"Bonato A","year":"2023","unstructured":"Bonato A, Fisch P, Ponta S, et al.. Engineering inflammation-resistant cartilage: bridging gene therapy and tissue engineering. Adv Healthc Mater. 2023, 12:e2202271. 10.1002\/adhm.202202271","journal-title":"Adv Healthc Mater"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-025-09973-8","article-title":"Cell and gene therapy products: navigating the regulatory landscape of paradigm approvals in the US (2020 to 2024)","volume":"20","author":"Tandulje AA","year":"2025","unstructured":"Tandulje AA, Varpe PC, Chaugule PD, Saji S, Nizar F, Raghuvanshi RS, Srivastava S. Cell and gene therapy products: navigating the regulatory landscape of paradigm approvals in the US (2020 to 2024). J Pharm Innov. 2025, 20:63. 10.1007\/s12247-025-09973-8","journal-title":"J Pharm Innov"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030856","article-title":"Gene therapy for regenerative medicine","volume":"15","author":"Hosseinkhani H","year":"2023","unstructured":"Hosseinkhani H, Domb AJ, Sharifzadeh G, Nahum V. Gene therapy for regenerative medicine. Pharmaceutics. 2023, 15:856. 10.3390\/pharmaceutics15030856","journal-title":"Pharmaceutics"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2023.08.006","article-title":"Biomaterial-based scaffolds in promotion of cartilage regeneration: recent advances and emerging applications","volume":"41","author":"Liang J","year":"2023","unstructured":"Liang J, Liu P, Yang X, Liu L, Zhang Y, Wang Q, Zhao H. Biomaterial-based scaffolds in promotion of cartilage regeneration: recent advances and emerging applications. J Orthop Translat. 2023, 41:54-62. 10.1016\/j.jot.2023.08.006","journal-title":"J Orthop Translat"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7638245","article-title":"New insights into cartilage tissue engineering: improvement of tissue-scaffold integration to enhance cartilage regeneration","volume":"2022","author":"Jelodari S","year":"2022","unstructured":"Jelodari S, Ebrahimi Sadrabadi A, Zarei F, Jahangir S, Azami M, Sheykhhasan M, Hosseini S. New insights into cartilage tissue engineering: improvement of tissue-scaffold integration to enhance cartilage regeneration. Biomed Res Int. 2022, 2022:7638245. 10.1155\/2022\/7638245","journal-title":"Biomed Res Int"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01118-4","article-title":"Recent advancements in cartilage tissue engineering innovation and translation","volume":"20","author":"Nordberg RC","year":"2024","unstructured":"Nordberg RC, Bielajew BJ, Takahashi T, Dai S, Hu JC, Athanasiou KA. Recent advancements in cartilage tissue engineering innovation and translation. Nat Rev Rheumatol. 2024, 20:323-46. 10.1038\/s41584-024-01118-4","journal-title":"Nat Rev Rheumatol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.3325\/cmj.2024.65.268","article-title":"Tissue engineering and future directions in regenerative medicine for knee cartilage repair: a comprehensive review","volume":"65","author":"Primorac D","year":"2024","unstructured":"Primorac D, Molnar V, Tsoukas D, et al.. Tissue engineering and future directions in regenerative medicine for knee cartilage repair: a comprehensive review. Croat Med J. 2024, 65:268-87. 10.3325\/cmj.2024.65.268","journal-title":"Croat Med J"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1177\/23259671241275087","article-title":"Prolotherapy in the treatment of sports-related tendinopathies: a systematic review of randomized controlled trials","volume":"12","author":"Capotosto S","year":"2024","unstructured":"Capotosto S, Nazemi AK, Komatsu DE, Penna J. Prolotherapy in the treatment of sports-related tendinopathies: a systematic review of randomized controlled trials. Orthop J Sports Med. 2024, 12:10.1177\/23259671241275087","journal-title":"Orthop J Sports Med"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2019.10.005","article-title":"Recent advances in biomaterials for 3D scaffolds: a review","volume":"4","author":"Nikolova MP","year":"2019","unstructured":"Nikolova MP, Chavali MS. Recent advances in biomaterials for 3D scaffolds: a review. Bioact Mater. 2019, 4:271-92. 10.1016\/j.bioactmat.2019.10.005","journal-title":"Bioact Mater"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2016.03.002","article-title":"Cartilage tissue engineering: from biomaterials and stem cells to osteoarthritis treatments","volume":"59","author":"Vinatier C","year":"2016","unstructured":"Vinatier C, Guicheux J. Cartilage tissue engineering: from biomaterials and stem cells to osteoarthritis treatments. Ann Phys Rehabil Med. 2016, 59:139-44. 10.1016\/j.rehab.2016.03.002","journal-title":"Ann Phys Rehabil Med"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.05.009","article-title":"Gene- and RNAi-activated scaffolds for bone tissue engineering: current progress and future directions","volume":"174","author":"Laird NZ","year":"2021","unstructured":"Laird NZ, Acri TM, Tingle K, Salem AK. Gene- and RNAi-activated scaffolds for bone tissue engineering: current progress and future directions. Adv Drug Deliv Rev. 2021, 174:613-27. 10.1016\/j.addr.2021.05.009","journal-title":"Adv Drug Deliv Rev"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1245897","article-title":"Porous biomaterial scaffolds for skeletal muscle tissue engineering","volume":"11","author":"Kozan NG","year":"2023","unstructured":"Kozan NG, Joshi M, Sicherer ST, Grasman JM. Porous biomaterial scaffolds for skeletal muscle tissue engineering. Front Bioeng Biotechnol. 2023, 11:1245897. 10.3389\/fbioe.2023.1245897","journal-title":"Front Bioeng Biotechnol"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-019-0119-y","article-title":"Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components","volume":"27","author":"Maggio I","year":"2020","unstructured":"Maggio I, Zittersteijn HA, Wang Q, et al.. Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components. Gene Ther. 2020, 27:209-25. 10.1038\/s41434-019-0119-y","journal-title":"Gene Ther"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2023.08.018","article-title":"Biofabrication methods for reconstructing extracellular matrix mimetics","volume":"31","author":"Aazmi A","year":"2024","unstructured":"Aazmi A, Zhang D, Mazzaglia C, et al.. Biofabrication methods for reconstructing extracellular matrix mimetics. Bioact Mater. 2024, 31:475-96. 10.1016\/j.bioactmat.2023.08.018","journal-title":"Bioact Mater"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214724","article-title":"Exploration of CRISPR\/Cas9-based gene editing as therapy for osteoarthritis","volume":"78","author":"Zhao L","year":"2019","unstructured":"Zhao L, Huang J, Fan Y, et al.. Exploration of CRISPR\/Cas9-based gene editing as therapy for osteoarthritis. Ann Rheum Dis. 2019, 78:676-82. 10.1136\/annrheumdis-2018-214724","journal-title":"Ann Rheum Dis"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.35630\/2026\/16\/Iss.1.016","article-title":"Comparative effectiveness of platelet rich plasma PRP stem cells and exosomes in the treatment of sports injuries a narrative review","volume":"16","author":"Spaczy\u0144ska-Kwiatkowska M","year":"2026","unstructured":"Spaczy\u0144ska-Kwiatkowska M, Ole\u015b P, Ko\u0142acz J, Kwiatkowski M, Bochniak P, W\u0142och T, Kozi\u0144ski T. Comparative effectiveness of platelet rich plasma PRP stem cells and exosomes in the treatment of sports injuries a narrative review. Arch Euromedica. 2026, 16:16-23. 10.35630\/2026\/16\/Iss.1.016","journal-title":"Arch Euromedica"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.26502\/josm.511500247","article-title":"Comparing regenerative biologics and standard pharmacotherapy for chronic rotator cuff tendinopathy: a study of PRP, cell-based, and peptide interventions","volume":"8","author":"Aabedi A","year":"2026","unstructured":"Aabedi A, Agrawal DK. Comparing regenerative biologics and standard pharmacotherapy for chronic rotator cuff tendinopathy: a study of PRP, cell-based, and peptide interventions. J Orthop Sports Med. 2026, 8:1-10. 10.26502\/josm.511500247","journal-title":"J Orthop Sports Med"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13112832","article-title":"Dual-action regenerative therapies: regeneration and antimicrobial effects of platelet- and marrow-derived biologics","volume":"13","author":"Yuan C","year":"2025","unstructured":"Yuan C, Ang SP, Hasoon JJ, et al.. Dual-action regenerative therapies: regeneration and antimicrobial effects of platelet- and marrow-derived biologics. Biomedicines. 2025, 13:2832. 10.3390\/biomedicines13112832","journal-title":"Biomedicines"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27031509","article-title":"Clinical applications of extracellular vesicles: promises and pitfalls","volume":"27","author":"Primorac D","year":"2026","unstructured":"Primorac D, Brlek P, Buli\u0107 L, et al.. Clinical applications of extracellular vesicles: promises and pitfalls. Int J Mol Sci. 2026, 27:1509. 10.3390\/ijms27031509","journal-title":"Int J Mol Sci"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1653964","article-title":"Applications of bone regenerative medicine in the foot and ankle: mechanisms, technologies, and therapeutic advances","volume":"13","author":"Yang L","year":"2025","unstructured":"Yang L, Li Y, Wang T, et al.. Applications of bone regenerative medicine in the foot and ankle: mechanisms, technologies, and therapeutic advances. Front Bioeng Biotechnol. 2025, 13:1653964. 10.3389\/fbioe.2025.1653964","journal-title":"Front Bioeng Biotechnol"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1688419","article-title":"Editorial: Recent advancements in musculoskeletal regenerative medicine","volume":"13","author":"Matta C","year":"2025","unstructured":"Matta C, Ramasamy B, Vinod E. Editorial: Recent advancements in musculoskeletal regenerative medicine. Front Cell Dev Biol. 2025, 13:1688419. 10.3389\/fcell.2025.1688419","journal-title":"Front Cell Dev Biol"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1007\/s43465-024-01189-1","article-title":"Artificial intelligence (AI): a potential game changer in regenerative orthopedics\u2014a scoping review","volume":"58","author":"Vaishya R","year":"2024","unstructured":"Vaishya R, Dhall S, Vaish A. Artificial intelligence (AI): a potential game changer in regenerative orthopedics\u2014a scoping review. Indian J Orthop. 2024, 58:1362-74. 10.1007\/s43465-024-01189-1","journal-title":"Indian J Orthop"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-025-00423-2","article-title":"Advancing osteoarthritis research: the role of AI in clinical, imaging and omics fields","volume":"13","author":"Ou J","year":"2025","unstructured":"Ou J, Zhang J, Alswadeh M, Zhu Z, Tang J, Sang H, Lu K. Advancing osteoarthritis research: the role of AI in clinical, imaging and omics fields. Bone Res. 2025, 13:48. 10.1038\/s41413-025-00423-2","journal-title":"Bone Res"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15131648","article-title":"Emerging diagnostic approaches for musculoskeletal disorders: advances in imaging, biomarkers, and clinical assessment","volume":"15","author":"Kumar R","year":"2025","unstructured":"Kumar R, Marla K, Sporn K, et al.. Emerging diagnostic approaches for musculoskeletal disorders: advances in imaging, biomarkers, and clinical assessment. Diagnostics (Basel). 2025, 15:1648. 10.3390\/diagnostics15131648","journal-title":"Diagnostics (Basel)"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00584-8","article-title":"Incorporation of \"artificial intelligence\" for objective pain assessment: a comprehensive review","volume":"13","author":"El-Tallawy SN","year":"2024","unstructured":"El-Tallawy SN, Pergolizzi JV, Vasiliu-Feltes I, et al.. Incorporation of \"artificial intelligence\" for objective pain assessment: a comprehensive review. Pain Ther. 2024, 13:293-317. 10.1007\/s40122-024-00584-8","journal-title":"Pain Ther"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.3390\/biomedinformatics5040069","article-title":"The application of artificial intelligence (AI) in regenerative medicine: current insights and challenges","volume":"5","author":"Abuarqoub D","year":"2025","unstructured":"Abuarqoub D, Mutahar M. The application of artificial intelligence (AI) in regenerative medicine: current insights and challenges. BioMedInformatics. 2025, 5:69. 10.3390\/biomedinformatics5040069","journal-title":"BioMedInformatics"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2025.101058","article-title":"Mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine: standardisation, bioengineering and clinical translation","volume":"31","author":"Shimizu Y","year":"2026","unstructured":"Shimizu Y, Inoue Y, Matsuura N, Ishii T, Sowa Y, Sunami H, Ntege EH. Mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine: standardisation, bioengineering and clinical translation. Regen Ther. 2026, 31:101058. 10.1016\/j.reth.2025.101058","journal-title":"Regen Ther"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.09.042","article-title":"Therapeutic strategy for exosome-based bone regeneration to osteoporosis: challenges and potential solutions","volume":"84","author":"Dayanandan AP","year":"2026","unstructured":"Dayanandan AP, Bello AB, Arai Y, Lee SJ, Lee SH. Therapeutic strategy for exosome-based bone regeneration to osteoporosis: challenges and potential solutions. J Adv Res. 2026, 84:361-85. 10.1016\/j.jare.2025.09.042","journal-title":"J Adv Res"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03906-w","article-title":"Advances in extracellular vesicle-based nanomedicine for regenerative orthopaedics","volume":"24","author":"Gil Izquierdo S","year":"2025","unstructured":"Gil Izquierdo S, Fern\u00e1ndez Pilar A, Rios JL, et al.. Advances in extracellular vesicle-based nanomedicine for regenerative orthopaedics. J Nanobiotechnology. 2025, 24:36. 10.1186\/s12951-025-03906-w","journal-title":"J Nanobiotechnology"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101834","article-title":"3D bioprinted scaffolds for osteochondral regeneration: advancements and applications","volume":"32","author":"Lu J","year":"2025","unstructured":"Lu J, Gao Y, Cao C, et al.. 3D bioprinted scaffolds for osteochondral regeneration: advancements and applications. Mater Today Bio. 2025, 32:101834. 10.1016\/j.mtbio.2025.101834","journal-title":"Mater Today Bio"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbae033","article-title":"Advances in 3D bioprinting for regenerative medicine applications","volume":"11","author":"Loukelis K","year":"2024","unstructured":"Loukelis K, Koutsomarkos N, Mikos AG, Chatzinikolaidou M. Advances in 3D bioprinting for regenerative medicine applications. Regen Biomater. 2024, 11:rbae033. 10.1093\/rb\/rbae033","journal-title":"Regen Biomater"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16060709","article-title":"Insight into the functional dynamics and challenges of exosomes in pharmaceutical innovation and precision medicine","volume":"16","author":"Sharma A","year":"2024","unstructured":"Sharma A, Yadav A, Nandy A, Ghatak S. Insight into the functional dynamics and challenges of exosomes in pharmaceutical innovation and precision medicine. Pharmaceutics. 2024, 16:709. 10.3390\/pharmaceutics16060709","journal-title":"Pharmaceutics"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1002\/der2.70000","article-title":"PRP, exosomes, and stem cells: an international perspective","volume":"5","author":"Singh N","year":"2024","unstructured":"Singh N, Brown A, Gold M. PRP, exosomes, and stem cells: an international perspective. Dermatol Rev. 2024, 5:145-54. 10.1002\/der2.70000","journal-title":"Dermatol Rev"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh JA","year":"2024","unstructured":"Welsh JA, Goberdhan DC, O'Driscoll L, et al.. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024, 13:e12404. 10.1002\/jev2.12404","journal-title":"J Extracell Vesicles"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15070298","article-title":"Computational and imaging approaches for precision characterization of bone, cartilage, and synovial biomolecules","volume":"15","author":"Kumar R","year":"2025","unstructured":"Kumar R, Sporn K, Prabhakar V, et al.. Computational and imaging approaches for precision characterization of bone, cartilage, and synovial biomolecules. J Pers Med. 2025, 15:298. 10.3390\/jpm15070298","journal-title":"J Pers Med"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1007\/s11705-025-2566-x","article-title":"Regenerative engineering AI: a new paradigm for the future of tissue regeneration","volume":"19","author":"Laurencin CT","year":"2025","unstructured":"Laurencin CT, Whitfield T, Argyrou C, Hosseini FS. Regenerative engineering AI: a new paradigm for the future of tissue regeneration. Front Chem Sci Eng. 2025, 19:95. 10.1007\/s11705-025-2566-x","journal-title":"Front Chem Sci Eng"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/527043-regenerative-medicine-in-the-management-of-musculoskeletal-pain-mechanisms-clinical-applications-and-future-directions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:56:42Z","timestamp":1789811802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/527043-regenerative-medicine-in-the-management-of-musculoskeletal-pain-mechanisms-clinical-applications-and-future-directions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":141,"URL":"https:\/\/doi.org\/10.7759\/cureus.116523","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,19]]}}}